Skip to content

Home
Solution
Science
Company
Resources

Home
Solution
Science
Company
Resources
Contact us

Contact us

Journey Resource Center

Blog

Kidney Care in Diabetes: The Role of Tech and Medications

March 25, 2024

Lifestyle Tips for Kidney Health and Diabetes

Blog

Lifestyle Tips for Kidney Health & Diabetes

March 18, 2024

Blog

Know Your Numbers: Key Tests for Kidney Health

March 11, 2024

Blog

Diabetes & Kidney Health: A Vital Connection

March 4, 2024

News

Our Journey Continues: Opening Access to Millions with Diabetes

January 18, 2024

Product Guide

NaviDKD: Instructions for Use

October 16, 2023

Journey Biosciences Named Rising Star Finalist for Digital Health Awards

News

Journey Biosciences Named Finalist in Digital Health Hub Foundation’s Annual Awards

September 26, 2023

Digital Health Awards: Journey Biosciences Quarterfinalist Badge

News

Journey Biosciences Named a 'Rising Star' Quarterfinalist in Prestigious Digital Health Awards

September 5, 2023

News

Journey Biosciences Selected for StartUp Health’s T1D Moonshot

March 23, 2023

News

AMA Grants Journey Biosciences CPT® PLA Code for NaviDKD®

January 9, 2023

Blog

Looking Ahead to 2023 With Hope

January 4, 2023

News

Journey Biosciences launches NaviDKD® to predict diabetes-related kidney complications

December 1, 2022

First Prev 1 2 3 Next Last

support@journeybio.life
(877) 618-1005

Home

Solution
Science

Company

Resources
Contact Us
Privacy Policy
Terms and Conditions

NaviDKD is a Lab Developed Test (LDT) developed and its performance characteristics were determined by Journey Biosciences. NaviDKD is performed in a CLIA certified laboratory and is intended for clinical purposes. NaviDKD has not been cleared by the US Food and Drug Administration. NaviDKD has been clinically validated and indicated for use as an aid to predict patients at risk for developing Diabetes-Related Kidney Disease (DKD) at a time in its development when appropriate preventative treatments can be initiated. NaviDKD is indicated for use in individuals 18 years of age or older diagnosed with Type 1, Type 2 or LADA diabetes.